Nonhuman Primate Core Humoral Immunology Laboratory for AIDS Vaccine Research and Development
Nonhuman Primate Core Humoral Immunology Laboratory for AIDS Vaccine Research and Development
批准号:
10379050
负责人:
CELIA LABRANCHE
金额:
$238.2万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-03-30 至 2022-03-29
关键词:
AIDS VaccinesAcquired Immunodeficiency SyndromeAnimalsAntiviral AgentsBiological AssayContractorContractsDetectionEnsureEpidemicHIVHIV vaccineHIV/SIV vaccineImmune responseImmunizationImmunizeImmunologic TestsImmunologicsImmunologyInfectionInfection preventionLaboratoriesLeadMissionModelingNational Institute of Allergy and Infectious DiseasePrevention strategyReproducibilityResearch PersonnelResearch SupportSIVSIV VaccinesSiteStandardizationTestingUnited States National Institutes of HealthVaccinesVirusVirus Replicationimmunogenicityimprovedneutralizing antibodynonhuman primatepre-clinicalresearch and developmentsimian human immunodeficiency virustherapy developmentvaccine evaluationvirology
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The mission of the Division of AIDS (DAIDS), National Institute of Allergy and Infectious Diseases (NIAID) is to ensure an end to the human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) epidemic by supporting research that can lead to the development of therapies, vaccines, and prevention strategies. Nonhuman primate (NHP) models present the opportunity to test a variety of candidate AIDS vaccines, optimizing their ability to elicit immune responses and testing their ability to prevent infection or to control virus replication after virus challenge. DAIDS provides immunological and virological support for NHP studies conducted at NIAID’s Simian Vaccine Evaluation Unit (SVEU) contract sites and by AIDS vaccine researchers through three Nonhuman Primate Immunology and Virology Laboratories for AIDS Vaccine Research and Development (NHP Core Labs) contracts. The objective of these Core Laboratories has been to ensure standardization and comparability of the assays conducted for preclinical NHP studies and to provide a common basis for assessment of the immunogenicity and efficacy of candidate HIV and SIV vaccines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金